Skip to main content

Kevin Harley, Tim Orpin, Richard Shen

Illumina announced a number of personnel changes during its third-quarter conference call last week.
 
Kevin Harley has joined the firm as vice president of human resources. He previously held a similar position at Intralase. Before Intralase, Harley worked at Edwards Lifesciences and Baxter Healthcare, Illumina said.
 
Tim Orpin has also joined the company as general manager of Asia Pacific and Japan. Orpin served previously as vice president, Asia Pacific, for Applied Biosystems.
 

Additionally, Illumina said that Richard Shen has been promoted to vice president of assay biochemistry and reagent manufacturing. He previously served as senior director of array biochemistry.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.